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Abstract Autosomal-recessive cerebellar ataxias (ARCA)
are clinically and genetically heterogeneous conditions pri-
marily affecting the cerebellum. Mutations in the PNPLA6
gene have been identified as the cause of hereditary spastic
paraplegia and complex forms of ataxia associated with retinal
and endocrine manifestations in a field where the genotype-
phenotype correlations are rapidly expanding. We identified
two cousins from a consanguineous family belonging to a
large Zoroastrian (Parsi) family residing in Mumbai, India,
who presented with pure cerebellar ataxia without
chorioretinal dystrophy or hypogonadotropic hypogonadism.
We used a combined approach of clinical characterisation,
homozygosity mapping, whole-exome and Sanger sequenc-
ing to identify the genetic defect in this family. The phenotype
in the family was pure cerebellar ataxia. Homozygosity map-
ping revealed one large region of shared homozygosity at
chromosome 19p13 between affected individuals. Within this
region, whole-exome sequencing of the index case identified
two novel homozygous missense variants in the PNPLA6
gene at c.3847G>A (p.V1283M) and c.3929A>T
(p.D1310V) in exon 32. Both segregated perfectly with the
disease in this large family, with only the two affected cousins
being homozygous. We identified for the first time PNPLA6
mutations associated with pure cerebellar ataxia in a large
autosomal-recessive Parsi kindred. Previous mutations in this
gene have been associated with a more complex phenotype
but the results here suggest an extension of the associated
disease spectrum.
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Introduction
Autosomal-recessive cerebellar ataxia (ARCA) comprises a
heterogeneous group of neurodegenerative conditions
inherited in autosomal-recessive fashion with primary affec-
tion of the cerebellum. There are variable associated neuro-
logical signs such as spasticity, seizures, optic atrophy, neu-
ropathy and cognitive impairment with an ever-growing num-
ber of causative genes identified [1, 2]. With the advent of
whole-exome and whole-genome sequencing (WES and
WGS) for research and diagnostics, gene discovery has ad-
vanced in many ways with new genes and genotype-
phenotype correlations [3].
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Mutations in the patatin-like phospholipase domain-
containing protein 6 (PNPLA6) gene were originally described
in 2008 as causative for specific forms of complicated hered-
itary spastic paraplegia (SPG39, MIM#612020) [4]. Recently,
using a whole-exome sequencing approach, PNPLA6 muta-
tions were additionally identified as the most frequent unifying
genetic cause of two distinct clinical syndromes with previous-
ly elusive genetic origin: Boucher-Neuhauser (BNHS, MIM
#215470) and Gordon Holmes syndromes (GDHS, MIM
#212840). Subsequently, this gene was associated with a broad
neurodegenerative spectrum, frequently including ataxia, mo-
tor neuron disease, chorioretinal dystrophy and hypogonadism
[5, 6], and recently, PNPLA6 was independently identified as
the genetic cause in several families with Laurence-Moon syn-
drome (LNMS, MIM #245800), Oliver-McFarlane syndrome
(OMCS, MIM #275400) and Leber congenital amaurosis
(LCA1, MIM #204000) [7, 8].
Here, we report a large consanguineous Indian Parsi family
with pure cerebellar ataxia in two affected cousins. Using
homozygosity mapping and whole-exome sequencing, two
novel homozygous missense changes in the PNPLA6 gene
were identified. To our knowledge, this is the first report as-
sociating PNPLA6 mutations with pure cerebellar ataxia.
Patients and Methods
Patients
The patients were from a large, multigenerational consanguin-
eous family of Zorastrians (Parsis) of Indian origin with two
affected cousins, both born to consanguineous first-cousin
marriages (Fig. 1). The Zoroastrians are a tiny and closed
community who are followers of the pre Christian prophet
Zoroaster/Zarathustra.
The index patient was first seen 55 years ago at the age of 16
(NW, Mumbai), diagnosed as having spinocerebellar ataxia
(SCA) and underwent periodic clinical follow-up. At the age
of 57, he was seen together with his affected cousin at the
Department of Assisted Reproduction and Genetics, Jaslok
Hospital where thorough neurological and general medical ex-
amination (JD), pedigree analysis, karyotyping and chromo-
some breakage studywere carried out, genetic counselling given
and further testing coordinated. SCAs 1, 2, 3, 6, 7, 11, and 15,
DRPLA, Friedreich ataxia, Fragile-X and Huntington disease
were excluded and a genetic diagnosis could not be reached.
Genetic Analyses
With the approval of the joint ethics committee of UCL
Institute of Neurology and the National Hospital for
Neurology and Neurosurgery, London, UK (UCLH: 04/
N034), DNA and RNA were extracted from blood samples
of both cousins and 20 unaffected relatives who had given
their consent using standardized protocols. To determine the
genetic cause of the disease, we performed homozygosity
mapping in the two affected cousins and two unaffected fam-
ily members by using HumanOmniExpress BeadChip Kit
( I l l u m i n a ) a n d a n a l y s i n g t h e d a t a w i t h
HomozygosityMapper (http://www.homozygositymapper.
org/). Subsequently, WES was carried out in the index case
using NimbleGen SeqCap Target Enrichment EZ-system
(Roche Sequencing) and Illumina 76 bp paired end sequenc-
ing on a GAII platform as part of a commercial service.
Provided annotated variant files were analysed for homozy-
gous non-synonymous variants in the homozygous stretches
previously determined and other known genetic causes of cer-
ebellar ataxia outside these regions and detectable via exome
sequencing were confirmatory excluded. Sanger sequencing
was performed to confirm variants, test segregation, and
screen an additional cohort of 40 British pure cerebellar ataxia
patients (primers available upon request). To rule out possible
effects ofmutations on splicing, cDNAwas created fromRNA
and subsequently Sanger sequenced.
Results
Clinical Description
The index patient (Fig. 1: IV–7) developed slowly progressive
cerebellar symptoms with balance and coordination problems
primarily affecting gait and manual movements at the age of
12. He rarely cried as an infant, had nystagmus and poor
handwriting and was a double graduate, though needing a
writer for exams. The index case’s condition was significantly
exacerbated by a stroke due to thrombosis in the left transverse
sinus at age 60. In this context, an MRI was acquired that
showed severe cerebellar and some degree of midbrain atro-
phy (Fig. 2), and polycythemia vera was diagnosed and sub-
sequently controlled with medication and phlebotomy. It was
only after the stroke that vision was impaired due to the isch-
aemic event and subsequent falls led to parenchymal and sub-
dural haematomas causing aphasia, disorientation, aggression,
a very strong grip with stereotypy of hand and neck with the
head tilting backwards. He died one year ago at the age of 70.
Regarding the movement disorder, the paternal cousin of the
index patient (Fig. 1: IV−3, currently at age 68) developed
similar symptoms around puberty with pure cerebellar ataxia
leading to frequent falls and leg fractures, for which she is now
wheelchair bound. She has dysmetric slow saccades and be-
sides poor handwriting, she does not have any further compli-
cating symptoms being mentally alert, though speech is slow.
In both affected individuals, ataxic gait and brisk lower limb
reflexes suggested early onset cerebellar ataxia with retained
reflexes (EOCARR). Nerve conduction studies were within
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normal limits. EMG recordings were suggestive of bilateral
S1 segment lesion at the proximal level for both patients and
additional left L5 segment lesion at proximal level for the affect-
ed cousin (IV−3). There was no hypogonadotropic
hypogonadism or chorioretinal dystrophy in both of them.
Clinical data was available from 22 individuals of the family
(Fig. 1), whereof only the two reported cousins were found
symptomatic.
Genetic Analyses
Homozygosity mapping revealed only one large region of
shared homozygosity by the two affected cousins on
chromosome 19 (Supplementary Figure 1), spanning over
4 Mb (Chr19: 3630740–7759053). This region comprises
132 genes, from which two (ATCAY, PNPLA6) were particu-
larly interesting candidates given the phenotype of our pa-
tients. WES revealed one synonymous change in SAFB2 (un-
likely to be related with the disease) and two homozygous
missense changes in PNPLA6 at c.3847G>A (p.V1283M)
and c.3929A>T (p.D1310V) in exon 32, transcript
ENST00000414982 (see Fig. 3a for filtering strategy). The
PNPLA6 variants were confirmed by Sanger sequencing
(Fig. 3b) and segregated perfectly with the disease in all 20
unaffected and two affected individuals tested (Figs. 1 and
3b): Nine heterozygous carriers were detected in four
Fig. 1 Family tree with segregation status of homozygous changes at positions c.3847G>A, p.V1283M and c.3929A>T, p.D1310V (wt wildtype, mt
mutant, the arrow denotes the index case)
Fig. 2 T1-weighted sagittal MRI
of unaffected control proband
(left) and sagittal and coronal
MRI of index case at age 60
depicting severe cerebellar
atrophy circled in red and some
additional degree of midbrain
atrophy
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generations, and only the two affected cousins were homozy-
gous. All exons of ATCAYand PNPLA6were also screened by
Sanger sequencing and ruled out the presence of additional
variants that could have beenmissed byWES. Screening of 40
British patients with pure cerebellar phenotype revealed no
further mutations in PNPLA6. No additional mutations in
known autosomal recessive cerebellar ataxia genes were de-
tectable on the exome.
The variants found in our consanguineous family
(p.V1283M and p.D1310V, see Table 1 for summary)
are not present in public databases (Exome Sequencing
Project variant server (EVS), dbSNP, Exome Aggregation
Consortium (ExAC), Complete Genomics 69 (cg69) and
1000 Genomes). The PNPLA6 c.3929A>T, p.D1310V
was conserved across species (Table 1 and Fig. 3c),
and predicted to be disease causing by three prediction
tools (Table 1) . Since the variant c .3847G>A,
p.V1283M, with more benign predict ion scores
(Table 1), lies at the first nucleotide of exon 32, we
investigated potential effects on splicing (e.g. exon skip-
ping) by Sanger sequencing cDNA from the affected
cousins and their carrier and wildtype siblings. No splic-
ing changes were detected around exon 32 (see Fig. 3b).
Discussion
We identified the first PNPLA6mutations in a large kindred of
Indian Zorastrians (Parsis) affected by a pure autosomal-
recessive cerebellar syndrome. This patatin-like phospholipase
domain-containing 6 gene on chromosome 19 encodes neurop-
athy target esterase (NTE), a phospholipase that produces
glycerophosphocholine by deacetylation of intracellular phos-
phatidylcholine. It therefore has important roles in membrane
axona l in t eg r i t y, phospho l ip id t r a f f i ck ing and
phosphatidylcholine-metabolism [10–12]. NTE-activity can
be impaired by exposure to neurotoxic organophosphorous
(OP) compounds which can result in OP compound-induced
delayed neuropathy (OPIDN) and further neurological symp-
toms [13]. Clinical features are in part similar to thewidespread
symptoms we observe upon genetic impairment of NTE due to
mutations in PNPLA6 [5, 7, 8].
Recently, reports of biallelic mutations in the PNPLA6
gene originally causative for SPG39 [4] have extended the
phenotypic spectrum, frequency and geographic occurrence
[14], e.g. compound heterozygous mutations have been re-
ported in a sporadic BNS-patient with late-onset gait ataxia
and mild retinal changes [15], the first two non-Caucasian
Fig. 3 a Filtering strategy for variants in the exome of the index case. b
Sanger sequencing of affected index case with homozygous changes at
positions c.3847G>A, cDNA and c.3929A>T, gDNA (top-panels),
heterozygous unaffected (mid-panel), and wildtype unaffected relatives
(lower panel). No effects on splicing were observed for the c.3847G>A
mutation. c Multiple sequence alignment showing conservation across
species at the affected amino acid residues 1283 and 1310 (WT
wildtype, Mut mutant)
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PNPLA6 cases of Japanese origin have been published [16],
and PNPLA6 was identified as the genetic cause in several
families with Laurence-Moon syndrome (LNMS, MIM
#245800), childhood blindness, Oliver-McFarlane syndrome
(OMCS, MIM #275400) and Leber congenital amaurosis
(LCA1, MIM #204000) [7, 8]. Here, we present two novel
homozygous variants associated for the first time with a pure
cerebellar phenotype in a large kindred of Indian descent. The
more conserved and predicted deleterious variant
(c.3929A>T, p.D1310V) lies between the previously
published pathogenic mutation c.3365C>T, p.P1122L,
located in the catalytically active phospholipid-esterase-
domain and shown to cause BNS, and the farthest downstream
pathogenic mutation towards the C-terminal site, c.4048C>G,
p.R1362G, causing GHS [5]. It might therefore not have a
direct diminishing effect within the catalytic center, but an
indirect steric inhibition of the protein’s original conformation
is possible and its close proximity to the recently identified
mutational cluster within the C-terminal phospholipid esterase
domain might supports its possibly pathogenic role [5]. The
variant c.3847G>A, p.V1283M has non-deleterious
prediction scores and is likely to be a tolerated missense
variant in linkage disequilibrium. An additional impact of
this predicted benign variant towards the phenotype cannot
be ruled out though and until further proof of functional
pathogenicity becomes available the final interpretation of
both novel variants remains unclear.
Conclusion
According to all published reports to date, both variants we
found in PNPLA6 are novel and represent the first report of
PNPLA6 variants in individuals of Indian descent. This report
suggests a possible extension of the clinical spectrum of
PNPLA6 associated diseases to pure cerebellar ataxia and ar-
gues for PNPLA6-testing to be considered in cases of early-
onset cerebellar ataxia despite the absence of chorioretinal
dystrophy or hypogonadotropic hypogonadism that are regu-
larly associated with mutations in this gene [5, 6, 17].
Web Resources
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://
www.omim.org/
HomozygosityMapper: http://www.homozygositymapper.org/
NHLBI ExomeVariant Server EVS: evs.gs.washington.edu
1000 Genomes project: www.1000genomes.org
CompleteGenomics cg69 database:www.completegenomics.
com/public-data/69-Genomes
dbSNP: www.ncbi.nlm.nih.gov/projects/SNP
Exome Aggregation Consortium database: http://exac.
broadinstitute.org/
MutationTaster: http://www.mutationtaster.org/
PolyPhen2: http://genetics.bwh.harvard.edu/pph2
SIFT: http://sift.jcvi.org/
CADD: http://cadd.gs.washington.edu/home
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Table 1 Frequency and in silico predictions of homozygous, novel missense PNPLA6 variants identified in large Parsi-pedigree
Chr Position (hg19) Transcript Variant dbSNP, 1000 g,
ExAC, EVS, cg69
GERP scorea SIFTb Mutation taster PolyPhen2
19 7625900 ENST00000414982 c.3847G>A, p.V1283M absent 2.79 T N B
19 7625982 ENST00000414982 c.3929A>T, p.D1310V absent 3.81 D D P
GERPGenomic Evolutionary Rate Profiling, SIFT ‘Sorting Tolerant From Intolerant’,D deleterious/damaging/disease-causing, P possibly damaging,N
polymorphism, T tolerated, B benign
a Positive conservation scores represent a substitution deficit and indicate that a site may be under evolutionary constraint. Negative scores indicate that a
site is probably evolving neutrally. Positive scores scale with the level of constraint, such that the greater the score, the greater the level of evolutionary
constraint inferred to be acting on that site
b Using the ‘Sorting Tolerant From Intolerant’ algorithm [9], this tool predicts whether an amino acid substitution affects protein function based on the
degree of conservation of amino acid residues in sequence alignments derived from closely related sequences
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